362 | 0 | 39 |
下载次数 | 被引频次 | 阅读次数 |
总结刘凤斌教授运用育阴开淤法分期治疗自身免疫性肝病(AILD)的临证经验。认为AILD病机总属本虚标实,本虚多见肝肾阴虚,日久兼有脾虚、阳虚,标实多见气滞、血瘀、湿热、痰毒。临证主张以育阴开淤为治疗原则,在养肝肾之阴的基础上,采用因势利导的方法祛除导致机体淤滞的不同病理因素,同时根据AILD各期特点进行分期论治。AILD前期及无症状期,肝郁气滞脾虚明显,治宜疏肝解郁健脾,方以自拟方柴芍气滞汤加减;临床症状期邪气尤盛,正气亏虚明显,可见湿热、水湿、痰毒为患,治宜补气健脾、清热祛湿,方以四君子汤合茵陈五苓散加减;肝功能失代偿期湿热痰毒瘀阻肝络,治宜养血软肝、健脾化瘀,方以自拟方软肝养血汤加减。同时治疗全程注重补益肝肾,顾护阴液。
Abstract:This paper summarizes Professor LIU Fengbin's clinical experience in treating autoimmune liver disease(AILD) using the method of nourishing yin and removing stasis based on stage differentiation. He believes that the pathogenesis of AILD generally involves both deficiency in essence and excess in manifestation, with essence deficiency often presenting as liver and kidney yin deficiency, which may progress to spleen deficiency and yang deficiency over time. The excess manifestation commonly includes qi stagnation, blood stasis, damp-heat, and phlegm toxicity. Clinically, he advocates for the treatment principle of nourishing yin and removing stasis. On the foundation of nourishing liver and kidney yin, different pathological factors causing stasis are eliminated according to their nature.Treatment is also tailored to different stages of AILD. In the early and asymptomatic stages, liver qi stagnation and spleen deficiency are prominent, warranting a therapeutic approach of soothing the liver, regulating qi and strengthening the spleen. The modified Chaishao Qizhi Decoction (柴芍气滞汤) is used. During the symptomatic stage, pathogenic factors become more pronounced, often accompanied by a significant deficiency of vital qi, with damp-heat, water retention, and phlegm toxicity as key pathological features. The treatment should focus on strengthening the spleen and dispelling dampness, using modified Sijunzi Decoction (四君子汤) combined with Yinchen Wuling Powder (茵陈五 苓 散). In the liver function decompensation stage, vital qi is severely deficient while pathogenic factors persist, with damp-heat, phlegm toxicity, and blood stasis obstructing the liver collaterals. Treatment should focus on nourishing blood, softening the liver, strengthening the spleen, and resolving stasis, using the modified Ruangan Yangxue Decoction (软肝养血汤). Throughout the treatment process, emphasis is placed on tonifying the liver and kidneys while protecting yin fluids.
[1]LAPIERRE P, ALVAREZ F. Type 2 autoimmune hepatitis:genetic susceptibility[J]. Front Immunol, 2022,13:1025343. doi:10. 3389/fimmu. 2022. 1025343.
[2]FAN JH, LIU GF, LV XD, et al. Pathogenesis of autoimmune hepatitis[J]. World J Hepatol, 2021,13(8):879-886.
[3]骆巧,李刚.自身免疫性肝病药物治疗研究进展[J].陕西医学杂志,2022,51(10):1318-1321.
[4]GR?NBAEK L, OTETE H, BAN L, et al. Incidence,prevalence and mortality of autoimmune hepatitis in England1997-2015. A population-based cohort study[J]. Liver Int, 2020,40(7):1634-1644.
[5]TANAKA A. Autoimmune Hepatitis:2019 Update[J].Gut Liver, 2020,14(4):430-438.
[6]中华医学会肝病学分会.自身免疫性肝炎诊断和治疗指南(2021)[J].临床肝胆病杂志,2022,38(1):42-49.
[7]中国社会科学院语言研究所词典编辑室.现代汉语词典修订本[M].北京:商务印书馆,2001:1532.
[8]郭净,王菊勇,刘忠达.中医药与免疫的思考[J].中华中医药学刊,2013,31(9):1982-1984.
[9]张铁军,张雪娟,苗华为,等.董燕平教授从相火妄动论治疗自身免疫性疾病理论探讨[J].时珍国医国药,2017,28(1):225-226.
[10]张霞,罗丽婷,马鹤铭,等.自身免疫性肝病合并干燥综合征的研究现状[J].临床肝胆病杂志,2019,35(11):2592-2595.
[11]孙玉文,冯全生,刘家强,等.从基因组的稳定看肾精的微观维稳功能[J].辽宁中医杂志,2010,37(1):76-77.
[12]赵曼君,邢莉民,邵宗鸿.表观遗传调控B细胞在自身免疫性疾病发病机制中的作用[J].中国免疫学杂志,2022,38(1):124-128.
[13]池晓玲,黎胜,萧焕明,等. 69例自身免疫性肝炎患者中医体质特点分析[J].中医杂志,2016,57(6):492-495.
[14]郭兆娟,张晶璇,涂灿,等.关于中药潜在肝毒性若干问题的思考[J].中华中医药杂志,2020,35(11):5399-5402.
[15]MAYO MJ. Natural history of primary biliary cirrhosis[J]. Clin Liver Dis, 2008,12(2):277-288.
[16]崔娜娜,王绮夏,马雄.《2019年美国肝病学会实践指引和指南:成人和儿童自身免疫性肝炎的诊断与治疗》摘译[J].临床肝胆病杂志,2020,36(4):758-763.
[17]郭长存,时永全,尚玉龙,等.原发性硬化性胆管炎诊断及治疗指南(2021)[J].临床肝胆病杂志,2022,38(1):50-61.
[18]张松,张苗,侯雪楠,等.柴胡-白芍异病同治分子机制的网络药理学分析[J].中药新药与临床药理,2019,30(10):1200-1210.
[19]朱正望,付双楠,薛宁,等.蒲公英总黄酮对CCl4致大鼠肝损伤的保护作用[J].中成药,2022,44(11):3680-3686.
[20]陶庆雪,常硕,施卫兵,等.新安医学之黄疸病因机证治特色探析[J].现代中医药,2024,44(4):45-48.
[21]杜金梁,刘英娟,曹丽萍,等.猪苓多糖对四氯化碳诱导的建鲤肝细胞损伤中生化指标及CYP3A表达的影响[J].华中农业大学学报,2014,33(3):78-83.
[22]刘祥兰,徐颖,张钰泉,等.猪苓多糖降血脂抗大鼠酒精性脂肪肝的药理实验研究[J].中成药,2013,35(8):1760-1764.
[23]刘玉萍,邱小玉,刘烨,等.茵陈的药理作用研究进展[J].中草药,2019,50(9):2235-2241.
[24]王飞,陈宝根.鳖甲煎丸治疗肝纤维化[J].中医学报,2024,39(2):437-439.
[25]丁茂鹏,韦凌霞,王志旺,等.基于网络药理学研究鳖甲煎丸抗肝纤维化的作用机制[J].中成药,2021,43(10):2874-2878.
[26]闫辉,吕青涛.白花蛇舌草、半枝莲及其药对抗肿瘤活性的研究进展[J].现代肿瘤医学,2015,23(22):3353-3356.
基本信息:
DOI:10.13288/j.11-2166/r.2025.07.004
中图分类号:R249;R259
引用信息:
[1]杨希玲,雍秋红,黄超原等.刘凤斌运用育阴开淤法分期辨治自身免疫性肝病经验[J].中医杂志,2025,66(07):674-679.DOI:10.13288/j.11-2166/r.2025.07.004.
基金信息:
国家自然科学基金(82104549); 中国博士后科学基金(2020M672603,2021M700960); 广东省中医药重点学科建设项目(20220087)